Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
2
Mins
21 Jul 2020
Are Coping Strategies, Anxiety, and Depression Associated with Daily Physical Activity in Patients With Axial Spondyloarthritis?
Patients with axial spondyloarthritis (axSpA) who are more physically active experience less pain and better physical functioning…
6
Mins
21 Jul 2020
EULAR 2020 Interview: Ms Sue Oliver OBE
When I started my masters, I think that I was always keen to have a role where I could make a bit of a difference and so finding a way to do that felt right…
3
Mins
21 Jul 2020
Interview: Clinical Prof Daniel Wallace
Clinical Prof Daniel Wallace | Rheumatologist, Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center, Los Angeles, California, USA…
6
Mins
21 Jul 2020
Early Recognition and Treatment of Spondyloarthritis: A Timeless Challenge
Spondyloarthritis (SpA) is a chronic systemic rheumatic disease, the hallmark manifestation of which is inflammatory back pain, and may also involve…
2
Mins
21 Jul 2020
Improving Risk-Stratification of Patients with Rheumatoid Arthritis for Interstitial Lung Disease
Interstitial lung disease (ILD) is a common pulmonary manifestation of rheumatoid arthritis (RA). It has emerged in recent studies as a key prognostic…
2
Mins
21 Jul 2020
2019 Update of the Joint European League Against Rheumatism (EULAR) and European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) Recommendations for the Management of Lupus Nephritis
A significant proportion of patients with systemic lupus erythematosus develop renal disease, which has a major impact on the course of the disease…
9
Mins
21 Jul 2020
Editor’s Pick: Methotrexate and The Lung in Rheumatoid Arthritis
Methotrexate (MTX) is the most commonly used medication to treat RA. MTX pneumonitis (MTX-pneu) is a rare disease entity reported in MTX users.
2
Mins
21 Jul 2020
Using Educational Applications to Facilitate Understanding of the Anatomy and Function of the Brain and Explore the Effects of Clinical Fatigue as from the Patient Perspective
When discussing the impact of rheumatic disease states with patients living with these conditions, fatigue is often at the forefront of that discussion…
Loading posts...
« Previous
1
…
54
55
56
57
58
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View